1. Home
  2. MBIO vs CHEK Comparison

MBIO vs CHEK Comparison

Compare MBIO & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • CHEK
  • Stock Information
  • Founded
  • MBIO 2015
  • CHEK 2004
  • Country
  • MBIO United States
  • CHEK Israel
  • Employees
  • MBIO N/A
  • CHEK N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • MBIO Health Care
  • CHEK Health Care
  • Exchange
  • MBIO Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • MBIO 7.3M
  • CHEK 9.0M
  • IPO Year
  • MBIO N/A
  • CHEK 2015
  • Fundamental
  • Price
  • MBIO $2.80
  • CHEK $0.86
  • Analyst Decision
  • MBIO Strong Buy
  • CHEK
  • Analyst Count
  • MBIO 1
  • CHEK 0
  • Target Price
  • MBIO $100.00
  • CHEK N/A
  • AVG Volume (30 Days)
  • MBIO 412.6K
  • CHEK 69.1K
  • Earning Date
  • MBIO 03-10-2025
  • CHEK 02-25-2025
  • Dividend Yield
  • MBIO N/A
  • CHEK N/A
  • EPS Growth
  • MBIO N/A
  • CHEK N/A
  • EPS
  • MBIO N/A
  • CHEK N/A
  • Revenue
  • MBIO N/A
  • CHEK N/A
  • Revenue This Year
  • MBIO N/A
  • CHEK N/A
  • Revenue Next Year
  • MBIO N/A
  • CHEK N/A
  • P/E Ratio
  • MBIO N/A
  • CHEK N/A
  • Revenue Growth
  • MBIO N/A
  • CHEK N/A
  • 52 Week Low
  • MBIO $2.40
  • CHEK $0.56
  • 52 Week High
  • MBIO $74.50
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.74
  • CHEK 41.78
  • Support Level
  • MBIO $2.40
  • CHEK $0.81
  • Resistance Level
  • MBIO $3.04
  • CHEK $0.97
  • Average True Range (ATR)
  • MBIO 0.65
  • CHEK 0.10
  • MACD
  • MBIO 0.06
  • CHEK -0.02
  • Stochastic Oscillator
  • MBIO 9.30
  • CHEK 13.42

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: